Changes in the Immune Cell Repertoire for the Treatment of Malignant Melanoma

Immune checkpoint inhibitors (ICIs) have been used for the treatment of various types of cancers, including malignant melanoma. Mechanistic exploration of tumor immune responses is essential to improve the therapeutic efficacy of ICIs. Since tumor immune responses are based on antigen-specific immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Kenta, Okuyama, Ryuhei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658693/
https://www.ncbi.nlm.nih.gov/pubmed/36361781
http://dx.doi.org/10.3390/ijms232112991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658693/
https://www.ncbi.nlm.nih.gov/pubmed/36361781
http://dx.doi.org/10.3390/ijms232112991

Ejemplares similares